Schmidt, Frank Martin <br/><br/>
[Optimizing antidepressant pharmacotherapy in a case of inflammatory bowel disease and major depression].  [electronic resource] 

 -  Psychiatrische Praxis  Jul 2012 
 - 239-42 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1439-0876 
<br/><br/><label>Standard No.: </label>10.1055/s-0032-1305013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Anti-Inflammatory Agents--administration & dosage<br/>Antidepressive Agents, Tricyclic--adverse effects<br/>Colitis, Ulcerative--blood<br/>Combined Modality Therapy<br/>Cytochrome P-450 CYP2D6--genetics<br/>Depressive Disorder, Major--blood<br/>Dose-Response Relationship, Drug<br/>Genetic Carrier Screening<br/>Humans<br/>Liver--enzymology<br/>Male<br/>Mesalamine--adverse effects<br/>Metabolic Clearance Rate--genetics<br/>Mianserin--adverse effects<br/>Middle Aged<br/>Mirtazapine<br/>Patient Admission